thinkstockMay 6, 2014: Markets opened lower on Monday and sank slowly and surely for the rest of the day. The dollar weakened against the yen overnight removing some enthusiasm for risk in…
Merck has had its consumer products business on the market since the beginning of this year, and Tuesday it announced that it had sold the business to Germany-based Bayer for $14.2 billion.
This past week brought yet another swing taking the Dow Jones Industrial Average to within 30 points or so of an all-time record high. 24/7 Wall St, wanted to review the four…
Endocyte and Merck have terminated their joint late-stage study of an ovarian cancer treatment after the trials failed to show results. Endocyte expressed surprise at the recommendation to halt the trial.
Paul Ausick These are the top analyst upgrades, downgrades and initiations from Wall Street on Wednesday, April 30, 2014. They include ARM Holdings, Coach, Merck, Netflix, Sprint, 3D Systems and Twitter.
thinkstockApril 29, 2014: Markets opened higher on Tuesday getting a boost from energy and biotech stocks right at the start of trading. Economic data was both sparse and not supportive, with the…
Paul Ausick Merck & Co. reported mixed first-quarter 2014 results before markets opened Tuesday morning. The loss of market exclusivity continues to hurt the top line. Merck reaffirmed its forecast for the full year.
Paul Ausick The NYSE Arca Biotechnology Index fell nearly 9% between a peak on Jan. 22 and a low on Feb. 5. It jumped 23% over the next three weeks, and then gave it…
In a new research report, the Healthcare team at UBS took an in-depth look at the top companies that are making major advances in cancer therapeutics. Here is the UBS list of…
Johnson & Johnson reported better-than-expected first-quarter results before markets opened Tuesday morning. And the company boosted its earnings guidance for the full year.
Gilead Sciences may have been largely responsible for the drop in biotech stocks after politicians went after its drug costs, but an excessive multiyear performance also allowed sellers to keep exiting the…
thinkstockApril 9, 2014: Markets opened higher on Wednesday and then got a jolt higher following the afternoon release of the FOMC’s last meeting minutes. The minutes indicated to many investors and traders…
Paul Ausick ThinkstockThe short interest data for the first two weeks of March is out, and the results among the top high-yield safe dividend stocks are mixed. The biggest changes took place in the…
Wikimedia CommonsWith the U.S. pharmaceutical group, and particularly the specialty pharmaceutical names, under pressure over recent trading sessions, the large biotechnology stocks were not the lone rangers when it came to the…
thinkstockMarch 25, 2014: Markets opened higher on Tuesday but dipped sharply in the late morning on weakness in consumer discretionary, financial, and biotech stocks. The Dow and the S&P 500 held on…
